Those association analyses suggested that GDI2 expression was probably an independent risky factor for HCC patients, and significantly associated with clinicopathologic characteristics as T stage, pathologic stage, histologic grade and TP53 status. Here, GDI2 is linked to hepatocellular carcinoma.